Uridine treatment protects against blood–brain barrier disruption in a rat model of Li-pilocarpine-induced status epilepticus
Authors:
Open Access
- 19 August 2025
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 19, 1635247
Abstract
Introduction: Blood–brain barrier (BBB) disruption is one of the most striking changes triggered by status epilepticus, which deserves specific attention in terms of novel treatment approaches targeting epileptogenesis. Uridine is a pyrimidine nucleoside with neuroprotective, antiepileptic and antiepileptogenic effects; however, its mechanism of action is not fully characterized. In this study, we aimed to investigate the short-term outcomes of uridine treatment on status epilepticus-induced-BBB dysfunction in an animal model.Methods: Status epilepticus was induced by lithium and pilocarpine administration in male Sprague–Dawley rats which were post-treated with intraperitoneal injection of saline or uridine (500 mg/kg b.w.; twice a day) for 2 days. Blood–brain barrier structural integrity was assessed by measuring expressions of endothelial tight junction proteins zonula occludens-1 (ZO-1) and occludin, matrix metalloproteinases (MMP-2 and MMP-9), aquaporin-4 (AQP4) water channel and its anchoring protein α1-syntrophin in hippocampal tissue 48 h after SE. Additionally, BBB permeability was determined by measuring brain edema and serum S100B levels.Results: The data showed that uridine significantly prevented the reduction in ZO-1 and α1-syntrophin protein levels and attenuated serum S100B levels, indicating protective effects on BBB integrity and AQP4 polarization. In contrast, uridine enhanced brain water content in SE-induced rats, a finding that might be a result of maintained AQP4 polarization and enhanced cytotoxic edema.Discussion: Together, our results showed for the first time that post-seizure treatment with uridine provides protection against BBB disruption in an experimental SE model; nevertheless, the long-term effects of this treatment warrant further investigation.Keywords
This publication has 63 references indexed in Scilit:
- Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the hippocampus of lithium-pilocarpine-induced acute epileptic ratsMolecular Biology Reports, 2022
- Neuron Specific Enolase, S100-beta protein and progranulin as diagnostic biomarkers of status epilepticusJournal of Neurology, 2022
- Dietary supplement with nucleotides in the form of uridine monophosphate or uridine stimulate intestinal development and promote nucleotide transport in weaned pigletsJournal of the Science of Food and Agriculture, 2019
- Phase-Dependent Astroglial Alterations in Li–Pilocarpine-Induced Status Epilepticus in Young RatsNeurochemical Research, 2017
- Factors determining the density of AQP4 water channel molecules at the brain–blood interfaceBrain Structure and Function, 2016
- Mechanisms of Astrocyte-Mediated Cerebral EdemaNeurochemical Research, 2014
- Astroglial loss and edema formation in the rat piriform cortex and hippocampus following pilocarpine‐induced status epilepticusJournal of Comparative Neurology, 2010
- Increased seizure duration and slowed potassium kinetics in mice lacking aquaporin‐4 water channelsGlia, 2006
- Laminin‐induced aggregation of the inwardly rectifying potassium channel, Kir4.1, and the water‐permeable channel, AQP4, via a dystroglycan‐containing complex in astrocytesGlia, 2004
- Interaction of uridine with GABA binding sites in cerebellar membranes of the ratNeurochemical Research, 1983